• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对家族性高胆固醇血症患者实现全员覆盖的协作方法:CARE-FH方案。

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol.

作者信息

Jones Laney K, Williams Marc S, Ladd Ilene G, Cawley Dylan, Ge Shuping, Hao Jing, Hassen Dina, Hu Yirui, Kirchner H Lester, Kobylinski Maria, Lesko Michael G, Nelson Matthew C, Rahm Alanna K, Rolston David D, Romagnoli Katrina M, Schubert Tyler J, Shuey Timothy C, Sturm Amy C, Gidding Samuel S

机构信息

Heart and Vascular Institute, Geisinger, Danville, PA 17821, USA.

Genomic Medicine Institute, Geisinger, Danville, PA 17821, USA.

出版信息

J Pers Med. 2022 Apr 9;12(4):606. doi: 10.3390/jpm12040606.

DOI:10.3390/jpm12040606
PMID:35455722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9024715/
Abstract

The Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia (CARE-FH) study aims to improve diagnostic evaluation rates for FH at Geisinger, an integrated health delivery system. This clinical trial relies upon implementation science to transition the initial evaluation for FH into primary care, attempting to identify individuals prior to the onset of atherosclerotic cardiovascular disease events. The protocol for the CARE-FH study of this paper is available online. The first phase of the project focuses on trial design, including the development of implementation strategies to deploy evidence-based guidelines. The second phase will study the intervention, rolled out regionally to internal medicine, community medicine, and pediatric care clinicians using a stepped-wedge design, and analyzing data on diagnostic evaluation rates, and implementation, service, and health outcomes.

摘要

家族性高胆固醇血症全民协作诊疗方法(CARE - FH)研究旨在提高杰弗逊医疗集团(一个综合医疗服务体系)对家族性高胆固醇血症(FH)的诊断评估率。这项临床试验依靠实施科学将FH的初始评估转变为初级保健,试图在动脉粥样硬化性心血管疾病事件发生之前识别个体。本文中CARE - FH研究的方案可在网上获取。该项目的第一阶段专注于试验设计,包括制定实施策略以推行循证指南。第二阶段将研究干预措施,采用阶梯式楔形设计在区域内推广至内科、社区医学和儿科护理临床医生,并分析诊断评估率以及实施、服务和健康结果的数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27fa/9024715/c65eeccaad9c/jpm-12-00606-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27fa/9024715/c80434879d20/jpm-12-00606-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27fa/9024715/c65eeccaad9c/jpm-12-00606-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27fa/9024715/c80434879d20/jpm-12-00606-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27fa/9024715/c65eeccaad9c/jpm-12-00606-g002.jpg

相似文献

1
Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol.针对家族性高胆固醇血症患者实现全员覆盖的协作方法:CARE-FH方案。
J Pers Med. 2022 Apr 9;12(4):606. doi: 10.3390/jpm12040606.
2
Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.设计改善家族性高胆固醇血症家庭识别、级联检测及管理的实施策略:一种干预映射方法。
Front Health Serv. 2023 Apr 28;3:1104311. doi: 10.3389/frhs.2023.1104311. eCollection 2023.
3
Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.利用实施科学在初级保健中开发家族性高胆固醇血症筛查项目:CARE-FH 研究。
J Clin Lipidol. 2024 Mar-Apr;18(2):e176-e188. doi: 10.1016/j.jacl.2024.01.001. Epub 2024 Jan 4.
4
Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.制定实施策略以提高家族性高胆固醇血症患者对指南推荐治疗的接受度:一项方案。
Res Social Adm Pharm. 2020 Mar;16(3):390-395. doi: 10.1016/j.sapharm.2019.06.006. Epub 2019 Jun 15.
5
Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia.开发和优化创新性工具以解决家族性高胆固醇血症漏诊问题:家族性高胆固醇血症的识别方法、患者激活和级联检测。
Circ Genom Precis Med. 2021 Feb;14(1):e003120. doi: 10.1161/CIRCGEN.120.003120. Epub 2021 Jan 22.
6
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.美国临床内分泌医师协会和美国内分泌学会血脂异常管理与心血管疾病预防指南
Endocr Pract. 2017 Apr;23(Suppl 2):1-87. doi: 10.4158/EP171764.APPGL.
7
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.家族性高胆固醇血症基金会 CAscade 筛查以提高对家族性高胆固醇血症的认识和检测的注册研究的基本原理和设计。
Am Heart J. 2014 Mar;167(3):342-349.e17. doi: 10.1016/j.ahj.2013.12.008. Epub 2013 Dec 21.
8
A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.针对家族性高胆固醇血症(FH)个体降低心血管疾病风险的定制生活方式干预:PRO-FIT 随机对照试验的设计。
BMC Public Health. 2010 Feb 15;10:69. doi: 10.1186/1471-2458-10-69.
9
Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary care.家族性高胆固醇血症的临床决策支持(CDS-FH):初级保健中一项集群随机试验的原理和设计。
Am Heart J. 2022 May;247:132-148. doi: 10.1016/j.ahj.2022.02.005. Epub 2022 Feb 15.
10
Low-density lipoprotein apheresis: an evidence-based analysis.低密度脂蛋白单采术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2007;7(5):1-101. Epub 2006 Nov 1.

引用本文的文献

1
Translating Evidence-Based Guidelines Into Clinical Decision Support Tools to Improve Identification and Management of Familial Hypercholesterolemia.将基于证据的指南转化为临床决策支持工具,以改善家族性高胆固醇血症的识别与管理。
AMIA Annu Symp Proc. 2025 May 22;2024:1030-1039. eCollection 2024.
2
A guide to utilizing implementation science for genetic counseling.利用实施科学进行遗传咨询指南。
J Genet Couns. 2025 Jun;34(3):e70039. doi: 10.1002/jgc4.70039.
3
Beyond identification of familial hypercholesterolemia: Improving downstream visits and treatments in a large health care system: Improving FH Care.

本文引用的文献

1
Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis.提高高胆固醇血症患者他汀类药物利用率的实施策略:系统评价和荟萃分析。
Implement Sci. 2021 Apr 13;16(1):40. doi: 10.1186/s13012-021-01108-0.
2
Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis.评估多学科脂质门诊以改善严重脂质疾病患者的护理:一项RE-AIM框架分析
Implement Sci Commun. 2021 Mar 19;2(1):32. doi: 10.1186/s43058-021-00135-8.
3
Leveraging population-based exome screening to impact clinical care: The evolution of variant assessment in the Geisinger MyCode research project.
超越家族性高胆固醇血症的识别:改善大型医疗保健系统中的后续就诊和治疗:改善FH护理。
Am J Prev Cardiol. 2025 Jan 24;21:100937. doi: 10.1016/j.ajpc.2025.100937. eCollection 2025 Mar.
4
Implementation of a primary-tertiary shared care model to improve the detection of familial hypercholesterolaemia (FH): a mixed methods pre-post implementation study protocol.实施初级-三级共享护理模式以提高家族性高胆固醇血症(FH)的检出率:一项混合方法实施前后研究方案。
BMJ Open. 2024 May 1;14(5):e082699. doi: 10.1136/bmjopen-2023-082699.
5
Overcoming the real and imagined barriers to cholesterol screening in pediatrics.克服儿科胆固醇筛查中的实际和想象中的障碍。
J Clin Lipidol. 2024 May-Jun;18(3):e297-e307. doi: 10.1016/j.jacl.2024.02.008. Epub 2024 Mar 6.
6
Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.利用实施科学在初级保健中开发家族性高胆固醇血症筛查项目:CARE-FH 研究。
J Clin Lipidol. 2024 Mar-Apr;18(2):e176-e188. doi: 10.1016/j.jacl.2024.01.001. Epub 2024 Jan 4.
7
Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.设计改善家族性高胆固醇血症家庭识别、级联检测及管理的实施策略:一种干预映射方法。
Front Health Serv. 2023 Apr 28;3:1104311. doi: 10.3389/frhs.2023.1104311. eCollection 2023.
8
How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?如何利用实施科学改善家族性高胆固醇血症的治疗?
Curr Atheroscler Rep. 2023 Apr;25(4):133-143. doi: 10.1007/s11883-023-01090-6. Epub 2023 Feb 20.
9
Translating guidelines into practice via implementation science: an update in lipidology.通过实施科学将翻译指南转化为实践:脂质学的最新进展。
Curr Opin Lipidol. 2022 Dec 1;33(6):336-341. doi: 10.1097/MOL.0000000000000835. Epub 2022 Jun 27.
利用基于人群的外显子组筛查来影响临床护理:Geisinger MyCode 研究项目中变异评估的演变。
Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):83-94. doi: 10.1002/ajmg.c.31887. Epub 2021 Feb 11.
4
Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.家族性高胆固醇血症治疗的障碍、促进因素和解决方案。
PLoS One. 2020 Dec 23;15(12):e0244193. doi: 10.1371/journal.pone.0244193. eCollection 2020.
5
Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.家族性高胆固醇血症:设计适应性护理模式的知识演进。
Nat Rev Cardiol. 2020 Jun;17(6):360-377. doi: 10.1038/s41569-019-0325-8. Epub 2020 Jan 23.
6
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.20 年随访家族性高胆固醇血症患儿他汀类药物治疗。
N Engl J Med. 2019 Oct 17;381(16):1547-1556. doi: 10.1056/NEJMoa1816454.
7
Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.家族性高胆固醇血症成年患者的纵向低密度脂蛋白胆固醇目标达标与心血管结局:CASCADE FH 登记研究。
Atherosclerosis. 2019 Oct;289:85-93. doi: 10.1016/j.atherosclerosis.2019.08.007. Epub 2019 Aug 19.
8
Finding missed cases of familial hypercholesterolemia in health systems using machine learning.利用机器学习在医疗系统中发现家族性高胆固醇血症的漏诊病例。
NPJ Digit Med. 2019 Apr 11;2:23. doi: 10.1038/s41746-019-0101-5. eCollection 2019.
9
Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.制定实施策略以提高家族性高胆固醇血症患者对指南推荐治疗的接受度:一项方案。
Res Social Adm Pharm. 2020 Mar;16(3):390-395. doi: 10.1016/j.sapharm.2019.06.006. Epub 2019 Jun 15.
10
The FRAME: an expanded framework for reporting adaptations and modifications to evidence-based interventions.FRAME:一个扩展的报告基于证据的干预措施的适应性和修改的框架。
Implement Sci. 2019 Jun 6;14(1):58. doi: 10.1186/s13012-019-0898-y.